|
BlueRock's Phase I study with bemdaneprocel in patients with Parkinson's disease meets primary endpoint
|
30 August 2023 |
|
Mahana Therapeutics signs agreement with Consumer Health division of Bayer to commercialize digital therapeutics
|
22 August 2023 |
|
Aflibercept 8 mg first to achieve sustained vision gains with more than 70% of patients extended to intervals between 16 and 24 weeks in wet age-related macular degeneration at two years
|
10 August 2023 |
|
Bayer extends partnership with Peking University to foster pharmaceutical innovation in China
|
10 July 2023 |
|
Bayer's new pharmaceutical R&D strategy to accelerate breakthrough innovations
|
28 June 2023 |
|
Bayer to acquire exclusive license from Cedilla Therapeutics on selective inhibitors in pre-clinical precision oncology
|
13 June 2023 |
|
Bayer strengthens gene therapy portfolio with lipid nanoparticle technology from Acuitas Therapeutics
|
07 June 2023 |
|
Bayer launches unit to develop new precision health consumer products
|
31 May 2023 |
|
Bayer receives U.S. FDA Fast Track Designation for asundexian atrial fibrillation program
|
16 May 2023 |
|
Bayer opens first Co.Lab Life science incubator in Cambridge
|
10 May 2023 |
|
Bayer Pharmaceuticals accelerates innovations for patients
|
31 March 2023 |
|
BlueRock Therapeutics to incorporate wearable and invisible contactless digital health technologies from Rune Labs and Emerald Innovations in Parkinson's disease clinical trial
|
21 March 2023 |
|
Kerendia™ (finerenone) granted expanded indication in the EU for broad range of patients with chronic kidney disease and type 2 diabetes
|
13 February 2023 |
|
2022 Otto Bayer Award goes to Professor Frank Glorius
|
07 February 2023 |
|
CHMP recommends Bayer’s darolutamide for the treatment of metastatic hormone-sensitive prostate cancer
|
30 January 2023 |
|
Bayer to accelerate drug discovery with Google Cloud's high-performance compute power
|
12 January 2023 |
|
NextPoint Therapeutics announces $80 million Series B financing co-led by Leaps by Bayer and Sanofi Ventures to advance novel immuno-oncology programs
|
10 January 2023 |
|
Recombinant adeno-associated virus (rAAV) technology pioneered by AskBio's Dr. Jude Samulski is key component of all FDA approved AAV gene therapeutics
|
20 December 2022 |
|
Bayer launches industry-first public database listing company's science collaborations and partnerships in the U.S.
|
09 December 2022 |
|
Bayer supports rebuilding of Ukrainian healthcare system by donating 1.3 million euros
|
02 December 2022 |